Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Potential of resveratrol in the treatment of interstitial lung disease
Rongxiu Huo, Xinxiang Huang, Yanting Yang, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 12

Showing 12 citing articles:

Potential Therapeutic Targets of Resveratrol in the Prevention and Treatment of Pulmonary Fibrosis
Iman Ramli, Thamere Cheriet, Anna Maria Posadino, et al.
Frontiers in Bioscience-Landmark (2023) Vol. 28, Iss. 9
Open Access | Times Cited: 15
Resveratrol Supplementation in Wet AMD: Association With Fewer Intravitreal Injections and Reduced Macular Fibrosis
Ioannis Datseris, Alexandros Rouvas, Malvina-Efthymia Tzanidaki, et al.
Clinical ophthalmology (2025) Vol. Volume 19, pp. 217-225
Open Access
Researching New Drug Combinations with Senolytic Activity Using Senescent Human Lung Fibroblasts MRC-5 Cell Line
Maria Carolina Ximenes de Godoy, Juliana Alves Macedo, Alessandra Gambero
Pharmaceuticals (2024) Vol. 17, Iss. 1, pp. 70-70
Open Access | Times Cited: 4
Oxygen therapy for exercise capacity in fibrotic interstitial lung disease: A systematic review and meta-analysis of randomised controlled trials
Lee-Yuan Lin, Yu-Chih Wu, J.-J. Wu, et al.
Respiratory Medicine (2024) Vol. 227, pp. 107657-107657
Closed Access | Times Cited: 2
Resveratrol attenuates cyclosporin A-induced upregulation of the thromboxane A2 receptor and hypertension via the AMPK/SIRT1 and MAPK/NF-κB pathways in the rat mesenteric artery
Qian Li, Hanjing Cao, Xinya Xu, et al.
European Journal of Pharmacology (2024) Vol. 972, pp. 176543-176543
Closed Access | Times Cited: 1
Perspectives on Post-COVID-19 Pulmonary Fibrosis Treatment
Elena Cojocaru, Tudor Cojocaru, Giulia Mihaela Pînzariu, et al.
Journal of Personalized Medicine (2023) Vol. 14, Iss. 1, pp. 51-51
Open Access | Times Cited: 4
Dihydroquercetin-Loaded Liposomes Change Fibrous Tissue Distribution in the Bleomycin-Induced Fibrosis Model
E. V. Ivanov, M. R. Akhmetshina, Albina Gizatulina, et al.
Acta Naturae (2024) Vol. 16, Iss. 2, pp. 40-49
Open Access
Effects and medical application of plant-origin polyphenols: A narrative review
G Janigashvili, I Chkhikvishvili, L Ratiani, et al.
Bioactive Compounds in Health and Disease - Online ISSN 2574-0334 Print ISSN 2769-2426 (2024) Vol. 7, Iss. 8, pp. 375-385
Open Access
Screening, Identification and Targeted intervention of Necroptotic Biomarkers of Asthma
Ling Feng, Zhenzhen Wu, Xinyu Jia, et al.
Biochemical and Biophysical Research Communications (2024) Vol. 735, pp. 150674-150674
Open Access
Interrelation of Natural Polyphenol and Fibrosis in Diabetic Nephropathy
Ye Ma, Jiakun Wang, Jian‐Gao Fan, et al.
Molecules (2024) Vol. 30, Iss. 1, pp. 20-20
Open Access
A Narrative Review of Key Risk Factors for Severe Illness Following SARS-CoV-2, Influenza Virus, and Respiratory Syncytial Virus Infection
Angela R. Branche, Mayur Ramesh, Beverly M. Francis
Infectious Diseases and Therapy (2024)
Open Access
Traditional Herbal Medicines, Bioactive Compounds, and Plant Products as Therapeutic Approach Against Interstitial Lung Disease
Lovely Sinha, Saurabh Karmakar
(2023), pp. 339-380
Closed Access | Times Cited: 1
Page 1

Scroll to top